期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinicopathological aspects correlated with 1p/19q co-deletion in gliomas
1
作者 任晓辉 《外科研究与新技术》 2011年第3期207-208,共2页
Objective This study aims to select clinical and pathological aspects correlated with 1p /19q co-deletion in gliomas. Methods Samples of 56 glioma patients were collected. The status of chromosome 1p and 19q was detec... Objective This study aims to select clinical and pathological aspects correlated with 1p /19q co-deletion in gliomas. Methods Samples of 56 glioma patients were collected. The status of chromosome 1p and 19q was detected by Fluorescence in Situ Hybridization (FISH) and the expression levels of nine 展开更多
关键词 mgmt Clinicopathological aspects correlated with 1p/19q co-deletion in gliomas
下载PDF
Clinical management and survival outcomes of patients withdifferent molecular subtypes of diffuse gliomas in China(2011–2017):a multicenter retrospective study from CGGA 被引量:7
2
作者 Kenan Zhang Xing Liu +7 位作者 Guanzhang Li Xin Chang Shouwei Li Jing Chen Zheng Zhao Jiguang Wang Tao Jiang Ruichao Chai 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第10期1460-1476,共17页
Objective:We aimed to summarize the clinicopathological characteristics and prognostic features of various molecular subtypes of diffuse gliomas(DGs)in the Chinese population.Methods:In total,1,418 patients diagnosed ... Objective:We aimed to summarize the clinicopathological characteristics and prognostic features of various molecular subtypes of diffuse gliomas(DGs)in the Chinese population.Methods:In total,1,418 patients diagnosed with DG between 2011 and 2017 were classified into 5 molecular subtypes according to the 2016 WHO classification of central nervous system tumors.The IDH mutation status was determined by immunohistochemistry and/or DNA sequencing,and 1p/19q codeletion was detected with fluorescence in situ hybridization.The median clinical follow-up time was 1,076 days.T-tests and chi-square tests were used to compare clinicopathological characteristics.Kaplan‒Meier and Cox regression methods were used to evaluate prognostic factors.Results:Our cohort included 15.5%lower-grade gliomas,IDH-mutant and 1p/19q-codeleted(LGG-IDHm-1p/19q);18.1%lowergrade gliomas,IDH-mutant(LGG-IDHm);13.1%lower-grade gliomas,IDH-wildtype(LGG-IDHwt);36.1%glioblastoma,IDHwildtype(GBM-IDHwt);and 17.2%glioblastoma,IDH-mutant(GBM-IDHm).Approximately 63.3%of the enrolled primary gliomas,and the median overall survival times for LGG-IDHm,LGG-IDHwt,GBM-IDHwt,and GBM-IDHm subtypes were 75.97,34.47,11.57,and 15.17 months,respectively.The 5-year survival rate of LGG-IDHm-1p/19q was 76.54%.We observed a significant association between high resection rate and favorable survival outcomes across all subtypes of primary tumors.We also observed a significant role of chemotherapy in prolonging overall survival for GBM-IDHwt and GBM-IDHm,and in prolonging post-relapse survival for the 2 recurrent GBM subtypes.Conclusions:By controlling for molecular subtypes,we found that resection rate and chemotherapy were 2 prognostic factors associated with survival outcomes in a Chinese cohort with DG. 展开更多
关键词 Diffuse glioma IDH 1p/19q molecular pathology TEMOZOLOMIDE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部